Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands
Administered as injectable drugs, oral forms of GLP-1 drugs are another area of strong market interest, and Novo, Lilly and other companies are advancing oral GLP-1 agonists
DMPS has experimental status in the United States, while ALA is a common nutritional supplement
Wegovy is available as a higher strength, 2.4 mg once weekly, which may be more effective for weight loss
Ongoing long-term surveillance studies will provide more definitive answers as data mature
US$ 24.39
US$ 22.20
US$ 26.04
US$ 28.94
US$ 23.86
